Work

Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis

Year: 2019

Type: article

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2019.11.004

Authors: Marcus Shaker, John Oppenheimer, Dana Wallace, David M. Lang, Todd Rambasek, Mark Dykewicz, Matthew Greenhawt

Institutions: Dartmouth College, Dartmouth–Hitchcock Medical Center, Rutgers New Jersey Medical School, Nova Southeastern University, Cleveland Clinic, Ohio University, Saint Louis University, Children's Hospital Colorado, University of Colorado Anschutz

Language: English

Topic: Urticaria and Related Conditions

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Aimmune Therapeutics, Allergy Therapeutics, European Academy of Allergy and Clinical Immunology, Agency for Healthcare Research and Quality, Genentech, National Institute of Allergy and Infectious Diseases

Awards: Determining Tradeoffs Among Health Benefits, Adverse Events, and Resource Use Associated with Food Allergy Treatment, G726774268

OpenAlex ID: W2983321344

FWCI: 2.272

Cites: 33

Cited by: 23

Related to: 10